HAYLEY BOISSEAU: Open Payments
NPI 1275084261 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 46 payments from 9 companies in 2025. Trend: 2023 $333 · 2024 $130 · 2025 $1,251
Food & beverage: $1,251
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $514 |
| Alkermes, Inc. | 10 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $196 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| Vanda Pharmaceuticals Inc. | 3 | $80 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, REXULTI, FANAPT, Auvelity, SPRAVATO, LYBALVI.
Industry payments across NC — which companies pay providers there.
